Skip to main content
. 2022 Dec 9;2022:1349994. doi: 10.1155/2022/1349994

Table 2.

Management of patients.

Variable All patients
N = 106
ICU admission
N = 16
No ICU admission
N = 90
p value
Mechanical ventilation, N (%) 9 (8.7) 9 (69.2) 0 (0) <0.001
Vasopressors, N (%) 6 (5.7) 6 (37.5) 0 (0) <0.001
Use of steroids, N (%) 58 (54.7) 10 (62.5) 48 (53.3) 0.50
Initial daily dose (mg of prednisone or equivalent), median (Q1, Q3) 120 (40, 120) 50 (40, 105) 120 (50, 120) 0.02
Antimicrobial therapy, N (%)
 No initial antibiotic 7 (6.7) 0 (0) 7 (8) 0.60
 Fluoroquinolones 4 (3.8) 0 (0) 4 (4.5) 1.0
 Beta lactam alone 13 (12.3) 1 (6.3) 12 (13.3) 0.69
 Antipseudomonal beta lactam 7 (6.6) 2 (12.5) 5 (5.6) 0.28
 Beta lactam + azithromycin 43 (40.6) 3 (18.8) 40 (44.4) 0.06
 Antipseudomonal beta lactam + azithromycin 30 (28.3) 10 (62.5) 20 (22.2) 0.002
Oseltamivir, N (%) 73/106 (68.9) 10 (62.5) 63/90 (70) 0.55

ICU: intensive care unit, Q1: first quartile, and Q3: third quartile.